Open access peer-reviewed chapter

MTX Could Be First-Line Therapy Even in Cases Where hCG Level is Greater than 5,000 IU/ml

By Yoshiki Yamashita, Sousuke Katoh, Yoko Yoshida, Satoe Fujiwara, Sachiko Kawabe, Mika Hayashi, Atsushi Hayashi, Yoshito Terai and Masahide Ohmichi

Submitted: November 9th 2010Reviewed: May 10th 2011Published: October 26th 2011

DOI: 10.5772/20440

Downloaded: 2808

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Yoshiki Yamashita, Sousuke Katoh, Yoko Yoshida, Satoe Fujiwara, Sachiko Kawabe, Mika Hayashi, Atsushi Hayashi, Yoshito Terai and Masahide Ohmichi (October 26th 2011). MTX Could Be First-Line Therapy Even in Cases Where hCG Level is Greater than 5,000 IU/ml, Ectopic Pregnancy - Modern Diagnosis and Management, Michael Kamrava, IntechOpen, DOI: 10.5772/20440. Available from:

chapter statistics

2808total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

The Treatment of Ectopic Pregnancy with Laparoscopy-Assisted Local Injection of Chemotherapeutic Agents

By Ching-Hui Chen, Peng-Hui Wang, Li-Hsuan Chiu and Wei-Min Liu

Related Book

First chapter

Assisted Reproduction and Preterm Birth

By Offer Erez, Ruth Beer-Weisel, Tal Rafaeli-Yehudai, Idit Erez-Weiss and Moshe Mazor

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us